These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Psoriatic arthritis: update on pathophysiology, assessment and management. Mease PJ Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i77-84. PubMed ID: 21339225 [TBL] [Abstract][Full Text] [Related]
44. Inflammatory joint manifestations are prevalent in psoriasis: prevalence study of joint and axial involvement in psoriatic patients, and evaluation of a psoriatic and arthritic questionnaire. Alenius GM; Stenberg B; Stenlund H; Lundblad M; Dahlqvist SR J Rheumatol; 2002 Dec; 29(12):2577-82. PubMed ID: 12465155 [TBL] [Abstract][Full Text] [Related]
45. Initiative for quality in psoriasis and psoriatic arthritis. Boehncke WH; Adebajo A; Cauli A; Nash P; Salvarani C; Kavanaugh AF J Rheumatol; 2008 Jul; 35(7):1431-3. PubMed ID: 18609739 [TBL] [Abstract][Full Text] [Related]
46. [Psoriasis arthropathica]. Ruzicka T; Arenberger P; Wagner S; Peter RU; Kemeny L Ann Dermatol Venereol; 1993; 120(1):5-13. PubMed ID: 8338327 [TBL] [Abstract][Full Text] [Related]
48. Lack of genetic association of the three more common polymorphisms of CARD15 with psoriatic arthritis and psoriasis in a German cohort. Lascorz J; Burkhardt H; Hüffmeier U; Böhm B; Schürmeyer-Horst F; Lohmann J; Ständer M; Wendler J; Kelsch R; Baumann C; Küster W; Traupe H; Reis A Ann Rheum Dis; 2005 Jun; 64(6):951-4. PubMed ID: 15539411 [TBL] [Abstract][Full Text] [Related]
49. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study. Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368 [TBL] [Abstract][Full Text] [Related]
50. Perioperative management of medications for psoriasis and psoriatic arthritis: a review for the dermasurgeon. Hernandez C; Emer J; Robinson JK Dermatol Surg; 2008 Apr; 34(4):446-59. PubMed ID: 18248470 [TBL] [Abstract][Full Text] [Related]
51. Apremilast (otezla) for psoriatic arthritis. Med Lett Drugs Ther; 2014 May; 56(1443):41-2. PubMed ID: 24869713 [No Abstract] [Full Text] [Related]
52. Recommendations for the management and treatment of psoriatic arthritis. Carneiro S; Azevedo VF; Bonfiglioli R; Ranza R; Gonçalves CR; Keiserman M; Meirelles Ede S; Pinheiro Mde M; Ximenes AC; Bernardo W; Sampaio-Barros PD; Rev Bras Reumatol; 2013; 53(3):227-41. PubMed ID: 24051907 [No Abstract] [Full Text] [Related]
54. The History of Psoriatic Arthritis (PsA): From Moll and Wright to Pathway-Specific Therapy. Espinoza LR Curr Rheumatol Rep; 2018 Aug; 20(10):58. PubMed ID: 30094476 [TBL] [Abstract][Full Text] [Related]
55. MRI in psoriatic arthritis with hand and foot involvement. Ghanem N; Uhl M; Pache G; Bley T; Walker UA; Langer M Rheumatol Int; 2007 Feb; 27(4):387-93. PubMed ID: 17028861 [TBL] [Abstract][Full Text] [Related]
56. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Gladman DD; Antoni C; Mease P; Clegg DO; Nash P Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii14-7. PubMed ID: 15708927 [TBL] [Abstract][Full Text] [Related]